Company / Interest Expense
PULSE BIOSCIENCES, INC. Interest Expense History
FY2016-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$114.0K
FY2020
5-year range
-
FY2016-FY2020
Trend
-88.4%
vs FY2019
Sector context
#44 of 43
Health Care
What the data says
Among 43 Health Care companies, PULSE BIOSCIENCES, INC. is in the top -2% for interest expense. Improved from $418,000 to $114,000 over the past 2 years.
Based on SEC 10-K filings.
$114,000 in FY2020 with a 3-year CAGR of -22.7%.
Improved from $418,000 to $114,000 over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -22.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top -2% in Health CareTop -2% of 43This company $114.0K Sector average $324.8M
▼
-100.0% below sector average
Key checks
Key Insights
- 3-year CAGR of -22.7%, indicating a declining trend.
- In FY2020, interest expense decreased 88.4% year-over-year.
- Ranks #44 out of 43 companies in the Health Care sector.
- Peak interest expense was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.66 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | $114.0K | -88.4% |
| FY2019 | $983.0K | +135.2% |
| FY2018 | $418.0K | +69.2% |
| FY2017 | $247.0K | +263.2% |
| FY2016 | $68.0K | - |
As of FY2020 · SEC 10-K · Updated Jun 30, 2026